0.20CNY
40.19 MCNY
603.88 MCNY
104.03 M
About HUBEI GOTO BIOPHAR
Sector
Industry
CEO
Zu Bin Xi
Website
Headquarters
Xiangyang
Employees (FY)
537
Founded
2006
ISIN
CNE100004K94
FIGI
BBG00TP4M979
Hubei Goto Biopharm Co., Ltd. engages in the research, development, production, and sale of steroidal drug raw materials. The company was founded by Zu Bin Xi on May 15, 2006 and is headquartered in Xiangyang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 300966 is 14.49 CNY — it has decreased by 2.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUBEI GOTO BIOPHAR stocks are traded under the ticker 300966.
300966 stock is 3.73% volatile and has beta coefficient of 1.69. Check out the list of the most volatile stocks — is HUBEI GOTO BIOPHAR there?
Yes, you can track HUBEI GOTO BIOPHAR financials in yearly and quarterly reports right on TradingView.
300966 stock has fallen by 10.22% compared to the previous week, the month change is a 20.03% fall, over the last year HUBEI GOTO BIOPHAR has showed a 42.82% decrease.
300966 net income for the last quarter is 5.31 M CNY, while the quarter before that showed 13.45 M CNY of net income which accounts for −60.50% change. Track more HUBEI GOTO BIOPHAR financial stats to get the full picture.
Today HUBEI GOTO BIOPHAR has the market capitalization of 1.72 B, it has decreased by 7.27% over the last week.
HUBEI GOTO BIOPHAR dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0.33% and 20.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300966 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUBEI GOTO BIOPHAR stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 537.00 employees. See our rating of the largest employees — is HUBEI GOTO BIOPHAR on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUBEI GOTO BIOPHAR technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUBEI GOTO BIOPHAR stock shows the sell signal. See more of HUBEI GOTO BIOPHAR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.